Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Condition:   Crohn Disease Intervention:   Drug: Infliximab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials